|
|
|
|
|
|
 |
 |
 |
|
 |
 |
 |
Uromodulin Human ELISA
BioVendor Laboratory Medicine, Inc.
Serum Uromodulin ELISA - Specific and Sensitive Biomarker of Nephropathy •Low serum uromodulin (Tamm...
more »
|
 |
|
 |
|
|
|
|
|
|
 |
 |
 |
|
3 for the Price of 2 on Proteins and Antibodies!
PeproTech Promotional Offer
Buy any two Size A or B vials of Proteins or Antibodies and receive a third vial of equal or lesser value for free now through December 31, 2012.
*Excludes Animal-Free Products, ELISA Development Kits, Cytokine Packages and Media Supplements. Offer valid to End-User Clients only. Distributors, ...
more »
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
|
|
|
 |
| Better fluorescence intensity with Immunostep’s antibodies. |
 |
| From Immunostep |
 |
Immunostep, one of the leaders providing tools and services for bioscience research and diagnosis, has developed a broad range of high quality antibodies for Flow Cytometry, Cytokines and Growth Factors. This has allowed us to obtain antibodies that afford a better fluorescence intensity than other products available on the market. Moreover, Immunostep subjects all its antibodies to stringent testing such as repeatability, diagnostic sensitivity, analytical sensitivity or linearity, specificity and titre, thereby guaranteeing that all its products are suitable for diagnosis and research.
more » |
 |
|
|
|
|
|
|
|
 |
 |
 |
|
|
|
 |
Bio-Clinical Trials 2012
Bangalore, India
Under the evolving regulations for bio-clinical trials, adopting Good Clinical Practices (GCP) is a must for biopharmaceutical/biosimilars companies as well as CROs. Update yourself about these developments and more at the Global Bio-Clinical Trials conference, in India, and ensure you meet with ...
more » |
|
|
|
 |
14th Annual Immunogenicity for Biotherapeutics
Baltimore, MD
IIR’s Immunogenicity for Biotherapeutics has 14 years of proven history for giving industry leaders the tools and expertise they need in order to best design their immunoassays, preclinical research pipelines and molecular de-risking strategies! This year’s agenda features over 10 case studies to ...
more » |
|
|
|
|
|
|
| |
|
|